glp 1 pill America Has a New GLP-1 Playbook Clinically backed oral GLP What To Know About the

India Demand for GLP-1 receptor agonists in India is projected to rise at 8.4% CAGR through 2036

That has employers paying close attention: 77% of companies said managing GLP-1 costs is either an extremely important or very important priority this year, according to the Mercer survey

For patients who prefer oral medications over injections: Oral Wegovy (available January 2026) is the first FDA-approved oral GLP-1 for weight loss

54 mg/dL, respectively

2001;280(1):F10-18

Food and Drug Administration (FDA) recommendations announced in a 2008 call for evidence that therapies for type 2 diabetes do not increase the risk of cardiovascular events such as myocardial infarction (26)